The Sartorius VZ share was subjected to a thorough examination by Bernstein Research. These are the results found.
The US analysis house Bernstein Research left Sartorius on “Under Perperform” with a price target of 194 euros. Analyst Delphine Le Louet wrote of a “very strong fourth quarter of the laboratory and pharmaceutical supplier. A solid order intake saved the year 2024, she summed up in a quick assessment available on Tuesday.
Shares Check: A detailed look at the performance of the Sartorius VZ share at the time of the analysis
The paper from Sartorius VZ grew at 11:19 a.m. and rose by 13.2 percent to EUR 283.40 in Xetra trading. As a result, the paper still shows a return frightness of 31.55 percent in relation to the set course brand. Most recently, Sartorius VZ shares were implemented via Xetra 136,893. The stock has been up to 31.7 percent since the beginning of 2025. For the current annual quarter Q4 2024, on January 28, 2025 will be expected to submit the results.
New York (dpa-AfX analyzer) / Redaktion finanzen.net
Publication of the original study: 28.01.2025 / 08:20 / UTC
First passing on of the original study: 28.01.2025 / 08:20 / UTC
Note: Information on the obligation to disclose of the disclosure in the event of conflicts of interest within the meaning of Section 85 (1) WPHG, Art. 20 VO (EU) 596/2014 For the analysts mentioned can be found at http://web.dpa-afx.de/offengegungs/ opengungs_wecht.html.
Selected leverage products on Sartorius VZ.
With knock-outs, speculative investors can participate disproportionately in price movements. Simply choose the desired lever and we show you suitable open-end products on Sartorius VZ.
The lever must be between 2 and 20
Advertising
Image sources: T. Schneider / Shutterstock.com